Jpmorgan Chase & CO Xencor Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Xencor Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 130,354 shares of XNCR stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,354
Previous 126,719 2.87%
Holding current value
$3.15 Million
Previous $2.4 Million 9.3%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$15.7 - $21.65 $57,069 - $78,697
3,635 Added 2.87%
130,354 $2.62 Million
Q2 2024

Aug 12, 2024
SELL
$18.21 - $24.5 $45,379 - $61,054
-2,492 Reduced 1.93%
126,719 $2.4 Million
Q1 2024

May 10, 2024
SELL
$18.65 - $26.52 $6.94 Million - $9.86 Million
-371,956 Reduced 74.22%
129,211 $2.86 Million
Q4 2023

Feb 12, 2024
SELL
$16.53 - $21.42 $56,483 - $73,192
-3,417 Reduced 0.68%
501,167 $10.6 Million
Q3 2023

Nov 14, 2023
SELL
$20.08 - $25.39 $464,349 - $587,143
-23,125 Reduced 4.38%
504,584 $10.2 Million
Q2 2023

Aug 11, 2023
BUY
$24.77 - $29.9 $1.26 Million - $1.53 Million
51,042 Added 10.71%
527,709 $13.2 Million
Q1 2023

May 18, 2023
BUY
$25.95 - $36.95 $1.9 Million - $2.71 Million
73,325 Added 18.18%
476,667 $13.3 Million
Q1 2023

May 11, 2023
SELL
$25.95 - $36.95 $1.78 Million - $2.54 Million
-68,760 Reduced 14.56%
403,342 $11.2 Million
Q4 2022

Feb 13, 2023
SELL
$24.79 - $30.86 $566,377 - $705,058
-22,847 Reduced 4.62%
472,102 $12.3 Million
Q3 2022

Nov 14, 2022
SELL
$24.62 - $32.44 $292,731 - $385,711
-11,890 Reduced 2.35%
494,949 $12.9 Million
Q2 2022

Aug 11, 2022
SELL
$19.74 - $29.01 $54,778 - $80,502
-2,775 Reduced 0.54%
506,839 $13.9 Million
Q1 2022

May 11, 2022
SELL
$26.68 - $41.63 $223,791 - $349,192
-8,388 Reduced 1.62%
509,614 $13.6 Million
Q4 2021

Feb 10, 2022
SELL
$33.67 - $43.44 $357,676 - $461,463
-10,623 Reduced 2.01%
518,002 $20.8 Million
Q3 2021

Nov 12, 2021
BUY
$30.65 - $35.68 $16.2 Million - $18.9 Million
528,625 New
528,625 $17.3 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.44B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email